000 01323 a2200397 4500
005 20250515060117.0
264 0 _c20070928
008 200709s 0 0 eng d
022 _a0887-6924
024 7 _a10.1038/sj.leu.2404599
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRamirez, J M
245 0 0 _aPemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis.
_h[electronic resource]
260 _bLeukemia
_cApr 2007
300 _a797-804 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aGlutamates
_xpharmacology
650 0 4 _aGuanine
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aPemetrexed
650 0 4 _aTransplantation, Heterologous
700 1 _aOcio, E M
700 1 _aSan Miguel, J F
700 1 _aPandiella, A
773 0 _tLeukemia
_gvol. 21
_gno. 4
_gp. 797-804
856 4 0 _uhttps://doi.org/10.1038/sj.leu.2404599
_zAvailable from publisher's website
999 _c16873332
_d16873332